NCT04023773View on ClinicalTrials.gov

Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 30, 2027

Conditions

Liver Transplantation

Interventions

DEVICE

Liver Machine Perfusion (MP) device

Donor livers will have ex vivo continuous perfusion on the institutional-developed Liver MP device. The temperature of liver grafts will be controlled during perfusion.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors

lead

Koji Hashimoto

OTHER